跳至主要内容
临床试验/JPRN-UMIN000004934
JPRN-UMIN000004934已完成1 期

Feasibility study of adjuvant chemotherapy with FOLFOX(or XELOX) for 3 months followed by oral anticancer drug for 3 months in patients with completely resected colorectal cancer - Feasibility study of Sequential chemotherapy with L-OHP-based therapy followed by oral anticancer drug in patients with completely resected colorectal cancer (JSWOG C2 study)

PO Japan Southwest Oncology Research Support Organization(JSWOG)0 个研究点目标入组 80 人开始时间: 2011年2月1日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)a history of serious drug hypersensitivity or serious drug allergy. 2)active double cancer 3) women who are pregnant, lactating, or wish to become pregnant 4)a history of colorectal cancer 5)more than grade 1 (CTCAE v4.0) peripheral neuropathy 6)clinically significant heart disease 7) judged to be unsuitable for this trial due to clinically significant mental / psychological disease etc 8)clinically important infection or suspected infection in febrile patients. 9)diarrhea(watery) or diarrhea that interferes with daily activities for patients with a stoma. 10) dementia 11)diabetes with uncontrolled or accompanied neuropathy 12)judged to be ineligible by principal investigator for any other reason.

研究者

发起方
PO Japan Southwest Oncology Research Support Organization(JSWOG)

相似试验